Proposed changes to the statutory scheme to control the cost of branded health service medicines

Closed 17 Oct 2017

Opened 23 Aug 2017


Building on the consultation run in 2015, the Government is consulting further on proposals to amend the statutory scheme that controls the prices of branded health service medicines. The changes aim to align the cost savings to the NHS generated by the scheme more closely with those made by the current voluntary Pharmaceutical Price Regulation Scheme (PPRS), agreed in 2014. The statutory scheme covers those companies that decided not to join, or withdraw from, the 2014 PPRS, which is negotiated between the Government and the pharmaceutical industry.

The main proposals in the consultation are:

  • the introduction of a payment system similar to that in the 2014 PPRS;
  • making changes to the provisions on maximum prices, including removing the requirement for a 15% price cut; and
  • making changes to the information requirements placed on companies.

Draft regulations and a draft impact assessment have been published alongside this consultation.


  • Commissioners
  • Pharmacists
  • Foundation Trusts
  • NHS Commissioning Board
  • Clinical Commissioning Groups
  • Members of the public
  • Suppliers


  • Regulation